Robuta

Sponsor of the Day: Jerkmate
https://medcitynews.com/2026/04/travere-therapeutics-filspari-sparsentan-fda-approval-rare-kidney-disease-proteinuria-fsgs-tvtx/ Bouncing Back From Trial Failure, Travere Wins First FDA Approval in Rare Kidney Disease - MedCity... Apr 16, 2026 - Travere Therapeutics’ Filspari is now the first FDA-approved drug for focal segmental glomerulosclerosis (FSGS), a rare kidney disease. Analysts project the... rare kidney diseasebouncing backtrial failurewins firstfda approval https://www.biospace.com/drug-development/sarepta-plans-fda-run-for-duchenne-exon-skippers-despite-confirmatory-trial-failure Sarepta Plans FDA Run for Duchenne Exon Skippers Despite Confirmatory Trial Failure - BioSpace Mar 19, 2026 - Sarepta Therapeutics says the FDA has agreed to review a regulatory package for Amondys 45 and Vyondys 53 after they failed a confirmatory trial, but whether... trial failuresareptaplansfdarun https://www.biospace.com/jazz-s-future-in-ptsd-left-uncertain-following-mid-stage-trial-failure Jazz’s Future in PTSD Left Uncertain Following Mid-Stage Trial Failure - BioSpace Dec 22, 2023 - In a Phase II study, Jazz Pharmaceuticals’ investigational fatty acid amide hydrolase inhibitor JZP150 did not significantly improve post-traumatic stress... mid stagetrial failurefutureptsdleft https://www.nzherald.co.nz/rotorua-daily-post/news/rotorua-courthouse-air-conditioning-failure-delays-sexual-assault-jury-trial/LORHSO35JJCQHJZ4HJ3EFCRGVQ/ Rotorua courthouse air conditioning failure delays sexual assault jury trial - NZ Herald Apr 20, 2026 - A faulty air conditioning system at Rotorua’s Courthouse saw the room temperature plummet, forcing a delay in a sexual assault jury trial involving a young... air conditioningsexual assaultjury trialnz heraldrotorua